Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

QILU

  • FDA Approval
  • Sept. 17, 2025, 04:24 UTC
  • 45
  • 0 comments

FDA approve CYCLOSPORINE

Comment Full text

MEITHEAL

  • FDA Approval
  • Sept. 16, 2025, 08:48 UTC
  • 66
  • 0 comments

FDA approve HALOPERIDOL DECANOATE

Comment Full text

WATSON LABS

  • FDA Approval
  • Sept. 16, 2025, 08:48 UTC
  • 46
  • 0 comments

FDA approve METOPROLOL TARTRATE

Comment Full text

TEVA PHARMS USA INC

  • FDA Approval
  • Sept. 16, 2025, 08:48 UTC
  • 46
  • 0 comments

FDA approve MACITENTAN

Comment Full text

ASTRAZENECA

  • FDA Approval
  • Sept. 16, 2025, 08:48 UTC
  • 42
  • 0 comments

FDA approve ALBUTEROL SULFATE; BUDESONIDE

Comment Full text

HOSPIRA

  • FDA Approval
  • Sept. 16, 2025, 04:09 UTC
  • 48
  • 0 comments

FDA approve POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

Comment Full text

CORSTASIS THERAPEUTICS

  • FDA Approval
  • Sept. 15, 2025, 18:57 UTC
  • 44
  • 0 comments

FDA approve BUMETANIDE

Comment Full text

APOTEX INC

  • FDA Approval
  • Sept. 15, 2025, 08:54 UTC
  • 43
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Sept. 15, 2025, 08:54 UTC
  • 37
  • 0 comments

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • Sept. 15, 2025, 08:54 UTC
  • 47
  • 0 comments

FDA approve TERBINAFINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 88
  • 89
  • 90
  • 91
  • 92
  • Next

Search

News categories

  • Technical Exchange News(11313)
  • Event(2685)
  • SEC News(203419)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(133047)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin